ReviewWorld journal of clinical oncology2023

Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer.

Aya Abunada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.